fbpx
(561) 802-3060 info@mri-news.com

Medtronic Minimed 670G insulin pump

Type 1 Diabetes Clinical Study enrolling now in West Palm Beach FL

Qualified candidates will be:
• Men and women 18 to 80 years of age
• Diagnosed with Type 1 Diabetes for at least 1 year
• Currently using the Medtronic Minimed 670G Insulin Pump
• Willing to wear each Extended Wear Infusion Set for at least 174 hours (7days & 6 hours) or until infusion set failure

Additional eligibility criteria also apply.

Qualified participants will receive all study-related medications, laboratory tests and study-related supplies at no cost. You may also be reimbursed for your time and travel.

The Extended Wear Infusion Set (EWIS) is an investigational study. Its purpose is to collect data to support the safety and effectiveness of wearing the EWIS infusion set for 6 to 7 days. This study will last approximately 12 to 16 weeks, and will consist of 5 on-site and 2 telephone visits.

Important Safety Information for MiniMed™ 670G System: The MiniMed™ 670G is for type 1 ages 7 and over. Prescription required. Individual results may vary. WARNING: May not be safe under age 7 or using less than 8 units/day.

For more information, please call: (561) 802-3060, or visit: https: www.metabolic-institute.com/EWIS

Metabolic Research Institute Inc.
Barry S. Horowitz, MD, FACE – Principal Investigator
1515 N. Flagler Drive, Suite 440
West Palm Beach, FL 33401
Study Sponsor: Medtronic Diabetes 18000 Devonshire Street Northridge, CA 91325